Skip to content

COMPARISON of RETINA BLOOD FLOW VELOCITY by AO-SLO BETWEEN HEALTH GROUP AND POAG GROUP

THE FIRST CLINICAL COMPARISON of RETINA BLOOD FLOW VELOCITY by AO-SLO BETWEEN HEALTH GROUP AND POAG GROUP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086428
Enrollment
Unknown
Registered
2024-07-01
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POAG

Interventions

Sponsors

EYE and ENT HOSPITAL of FUDAN UNIVERSTIY
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Healthy group: 1) Age 30~65 years old, Chinese, gender unlimited 2) Fully cooperate with the instructions to complete the inspection 3) Spherical lens between +100 degrees to -300 degrees, BCAV=0.8 4) No history of internal eye disease, ocular surgery, or ocular trauma 5) IOP=21mmHg, no family history of eye diseases (including glaucoma and retinal diseases) 6) Subjects (or their designated agents) voluntarily participate and sign informed consent POAG group: 1) Meet the diagnostic criteria of POAG 2) Age 30~65 years old, Chinese, gender unlimited 3) Spherical lens between +100 degrees to -300 degrees, BCAV =0.8 4) No history of internal eye disease, ocular surgery history and ocular trauma history in the last 6 months

Exclusion criteria

Exclusion criteria: 1)History of systemic disease (hypertension, diabetes, autoimmune disease, etc.) 2) Eye axis length 25mm 3) The pupil area cannot be fully exposed for various reasons 4) The diopter medium is not clear and satisfactory images cannot be obtained 5) People who suffer from epidemic keratoconjunctivitis or are active in other infectious diseases 6) Special groups, such as pregnant women, minors, suffering from mental illness, etc 7) Any circumstances in which the investigator determines that participation in the trial is not appropriate

Design outcomes

Primary

MeasureTime frame
RETINA BLOOD FLOW VELOCITY;

Secondary

MeasureTime frame
General information;

Countries

CHINA

Contacts

Public ContactZHOUXINGTAO

EYE and ENT HOSPITAL of FUDAN UNIVERSTIY

871710308@qq.com+86 136 1175 1431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026